Stockreport

Avidity Biosciences Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag [Yahoo! Finance]

Avidity Biosciences, Inc.  (RNA) 
PDF All figures shown in the chart above are for the trailing 12 month (TTM) period Revenue missed analyst estimates by 49%. Earnings per share (EPS) exceeded analyst est [Read more]